NEW YORK (GenomeWeb News) - Pathway informatics firm Ingenuity Systems said today that it has inked a global licensing agreement with Tokyo-based drug maker Astellas Pharma.
Under the terms of the agreement, Astellas will use Ingenuity's Pathway Analysis software and will have access to the accompanying Pathway Knowledge Base database, which catalogs information about the relationships between genes, proteins, cells, tissues and diseases.
No financial terms of the agreement were released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.